These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6531784)

  • 41. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of [3H]estradiol- and [3H]H1285-receptor complexes to rabbit uterine chromatin.
    Singh RK; Ruh MF; Ruh TS
    Biochim Biophys Acta; 1984 Jul; 800(1):33-40. PubMed ID: 6743683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction and inhibition of estradiol hydroxylase activities in MCF-7 human breast cancer cells in culture.
    Niwa T; Bradlow HL; Fishman J; Swaneck GE
    Steroids; 1990 Jul; 55(7):297-302. PubMed ID: 2219196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conditions for the measurement of nuclear estrogen receptor at low temperature.
    Okulicz WC; Boomsma RA; MacDonald RG; Leavitt WW
    Biochim Biophys Acta; 1983 May; 757(1):128-36. PubMed ID: 6838903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen and antiestrogen binding to rat uterine and pituitary estrogen receptor: evidence for at least two physicochemical forms of the estrogen receptor.
    Jasper TW; Ruh MF; Ruh TS
    J Steroid Biochem; 1985 Nov; 23(5A):537-45. PubMed ID: 4079371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
    Bronzert DA; Greene GL; Lippman ME
    Endocrinology; 1985 Oct; 117(4):1409-17. PubMed ID: 4029083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assay of total estradiol receptor in tissue homogenate and tissue fractions by exchange with sodium thiocyanate at low temperature.
    Sica V; Weisz A; Petrillo A; Armetta I; Puca GA
    Biochemistry; 1981 Feb; 20(4):686-93. PubMed ID: 7213602
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Triphenylethylene antiestrogen-binding sites in cockerel liver nuclei: evidence for an endogenous ligand.
    Murphy PR; Butts C; Lazier CB
    Endocrinology; 1984 Jul; 115(1):420-6. PubMed ID: 6734522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of tamoxifen and tamoxifen derivatives on the conversion of estrone sulfate to estradiol in the MCF-7 mammary cancer cell line.
    Pasqualini JR; Gelly C
    Cancer Lett; 1988 Jun; 40(2):115-21. PubMed ID: 3383172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR; Murphy LC; Hall RE; Sutherland RL
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The estrogen receptor in MCF-7 cells: evidence from dense amino acid labeling for rapid turnover and a dimeric model of activated nuclear receptor.
    Scholl S; Lippman ME
    Endocrinology; 1984 Oct; 115(4):1295-301. PubMed ID: 6479094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer.
    Toko T; Shibata J; Nukatsuka M; Yamada Y
    Cancer Chemother Pharmacol; 1997; 39(5):390-8. PubMed ID: 9054952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
    J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen interaction with the anterior pituitary of female rats: Differential cytosol binding, nuclear translocation and stimulation of RNA synthesis by 17 beta-estradiol and tamoxifen.
    Spona J; Bieglmayer C; Leibl H
    Biochim Biophys Acta; 1980 Dec; 633(3):361-75. PubMed ID: 6163453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of [3H]estradiol--and [3H]H1285-receptor complexes: effect of salt versus ATP on molybdate-stabilized estrogen receptors.
    Singh RK; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Aug; 21(2):205-8. PubMed ID: 6482431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of tamoxifen and tamoxifen derivatives on the conversion of estrone-sulfate to estradiol in the R-27 cells, a tamoxifen-resistant line derived from MCF-7 human breast cancer cells.
    Gelly C; Pasqualini JR
    J Steroid Biochem; 1988; 30(1-6):321-4. PubMed ID: 2838692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estrogen down-regulation of androgen receptors in cultured human mammary cancer cells (MCF-7).
    Stover EP; Krishnan AV; Feldman D
    Endocrinology; 1987 Jun; 120(6):2597-603. PubMed ID: 3569146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand.
    Press MF; Xu SH; Wang JD; Greene GL
    Am J Pathol; 1989 Nov; 135(5):857-64. PubMed ID: 2683797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.